#RRMS
ACTRIMS-ECTRIMS 2026: RRMS Treatment and JCV Testing
zurl.co/ZFAsw
ACTRIMS-ECTRIMS 2026: RRMS Treatment and JCV Testing
Dr Shiv Saidha discusses remibrutinib's potential role in MS treatment and the implications of discordant JCV antibody testing for natalizumab care.
zurl.co
November 16, 2026 at 3:35 PM
Yes, it does! 🥺🫂
My RRMS changed to SPMS in 2002.
November 9, 2026 at 12:19 AM
#OPENACCESS: Tandem RRMs dance together while preserving the RNA-binding specificity providing evidence for highly dynamic and adaptable RNA recognition by tandem RRMs. buff.ly/521PW5u
Conformational plasticity and sequence specificity interplay in noncanonical tandem RRM-RNA binding
Dead end protein 1 (DND1), a key regulator of germline cell fate, utilizes two RNA recognition motifs (RRMs) in tandem to bind AU-rich RNA in a noncanonical manner. Only one RRM uses the known…
buff.ly
October 29, 2026 at 5:04 PM
При терапии рассеянного склероза препаратом моноклональных антител к В-клеточному антигену CD20 ритуксимабом повышен риск воспалительных заболеваний кишечника, особенно болезни Крона

https://nplus1.ru/news/2026/10/26/rituximab-rrms-and-ibd
October 26, 2026 at 8:50 AM
Did you know that we not only have cards that explain the different types of multiple sclerosis (relapsing remitting/secondary progressive/primary progressive), but we also have a huge range of cards that help communicate about symptoms and needs common to #MS - pain, visual impairment,
October 23, 2026 at 4:09 PM
When you look up what medication for MS you take since youre unspecified MS.

It treats all....

Briumvi (ublituximab-xiiy
It is indicated for clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary progressive MS (SPMS).
October 17, 2026 at 11:54 PM
rrms-closet.acggoods.com
October 9, 2026 at 5:06 PM
Probiotics linked to less fatigue and depression in relapsing-remitting MS multiplesclerosisnewstoday.com/news-posts/2...
Probiotics linked to less fatigue, disability in...
Adding probiotics to standard MS therapies may help to reduce fatigue, depression, and disability levels in RRMS, per data from a small trial.
multiplesclerosisnewstoday.com
October 8, 2026 at 9:00 AM
Discover more: https://bit.ly/4hLFwb8

Adding probiotics to standard MS therapies may help to reduce fatigue, depression, and disability levels in RRMS, per data from a small trial.

#MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews
Probiotics linked to less fatigue, disability in...
Adding probiotics to standard MS therapies may help to reduce fatigue, depression, and disability levels in RRMS, per data from a small trial.
bit.ly
October 7, 2026 at 12:12 AM
UK approval extends Ocrevus access to children with relapsing-remitting multiple sclerosis. https://www.mattheneus.com/editorial/mhra-ocrevus-paediatric-rrms-access-work-sharing-operetta2-2026-09-21 #HTA #RegulatoryAffairs #Pharma
October 1, 2026 at 4:03 PM
🎶 #Rammstein - Du Riechst So Gut 🎶
www.youtube.com/watch?v=rrms...
Rammstein - Du Riechst So Gut '98 (Official 4K Video)
YouTube video by Rammstein Official
www.youtube.com
September 25, 2026 at 8:05 AM
Imbalance of Circulating B-Cell Subsets Was Associated With Higher Risk of Relapses in RRMS Patients pubmed.ncbi.nlm.nih.gov/42773823/
September 25, 2026 at 2:25 AM
Take a closer look: https://bit.ly/4d2GEWo

MRI study finds signs of myelin and iron loss in RRMS, but not in AQP4-positive NMOSD, using a specialized imaging technique.

#MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews
MRI study finds U-fiber myelin loss, iron changes in RRMS
MRI study finds signs of myelin and iron loss in RRMS, but not in AQP4-positive NMOSD, using a specialized imaging technique.
bit.ly
September 24, 2026 at 3:45 PM
I was diagnosed about 20 years ago. I was working up to a couple years ago. I flipped from RRMS to secondary progressive.
September 22, 2026 at 5:52 AM
Discover more: https://bit.ly/4rr6QjB

Tiziana has inked a deal to support a clinical trial testing its experimental treatment foralumab in people with hard-to-treat RRMS.

#MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews
Tiziana inks deal for trial to test its experimental treatment in RRMS
Tiziana has inked a deal to support a clinical trial testing its experimental treatment foralumab in people with hard-to-treat RRMS.
bit.ly
September 21, 2026 at 3:45 PM
Tiziana Life Sciences and Saudi Arabia's KAIMRC to trial intranasal foralumab combined with anti-CD20 therapy in treatment-resistant RRMS patients.
Tiziana Life Sciences signs KAIMRC MOU for RRMS combination trial
Tiziana will collaborate with Saudi Arabia's KAIMRC on a clinical trial combining intranasal foralumab with anti-CD20 therapy in poorly responding RRMS patients.
biotech.disruptsmedia.com
September 21, 2026 at 9:22 AM
Minocycline has immunomodulatory and neuroprotective activities in vitro and in an animal model of multiple sclerosis (MS). We have previously reported that minocycline decreased gadolinium-enhancing activity over six months in a small t...
#MSchat #MS #Neurology #MultipleSclerosis #NeuroSky #MedSky
The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study
Minocycline has immunomodulatory and neuroprotective activities in vitro and in an animal model of multiple sclerosis (MS). We have previously reported that minocycline decreased gadolinium-enhancing activity over six months in a small trial of patients with active relapsing-remitting MS (RRMS). ...
brain-regeneration.com
September 20, 2026 at 3:00 PM
Get the scoop: https://bit.ly/46sfWCW

Greater disability levels are associated with more severe depression among people with RRMS, according to a study in Egypt.

#MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews
Greater disability linked to more severe depression in RRMS study
Greater disability levels are associated with more severe depression among people with RRMS, according to a study in Egypt.
bit.ly
September 18, 2026 at 3:44 PM
New clinical trial
A Prospective Longitudinal Multicenter, Multi-Country, Observational Study Assessing Patient Satisfaction After Subcutaneous Ocrelizumab Administration in Persons With Relapsing-Remitting Multiple Sclerosis (SONATA-MS)

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology
A Prospective Longitudinal Multicenter, Multi-Country, Observational Study Assessing Patient Satisfaction After Subcutaneous Ocrelizumab Administration in Persons With Relapsing-Remitting Multiple Sclerosis (SONATA-MS)
The main purpose of the study is to assess patient-reported satisfaction with subcutaneous (s.c.) ocrelizumab administration in participants with relapsing-remitting multiple sclerosis (RRMS) who are treatment-naive, switching from intravenous (i.v.) ocrelizumab to s.c. ocreli...
brain-regeneration.com
September 18, 2026 at 5:40 PM
Ich warte bis es dunkel ist
dann fass ich an die nasse Haut
verrate mich nicht
oh siehst du nicht die Brücke brennt
hör auf zu schreien und wehre dich nicht
weil sie sonst auseinander bricht

www.youtube.com/watch?v=rrms...
September 10, 2026 at 11:59 AM
Discover more: https://bit.ly/4x8IfAZ

Scientists found subtle changes in the brain's white matter that had appeared normal on MRI scans of people with early relapsing-remitting MS.

#MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews
Scientists tie early RRMS to subtle changes in brain white matter
Scientists found subtle changes in the brain's white matter that had appeared normal on MRI scans of people with early relapsing-remitting MS.
bit.ly
September 2, 2026 at 7:24 PM